EBV and Multiple Sclerosis: Could Infection Hold the Key to MS?
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
Epstein–Barr virus (EBV) has become one of the most intensely studied topics in multiple sclerosis research. But how strong is the evidence linking EBV to MS, and could targeting the virus change the future of treatment and prevention?
In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Gavin Giovannoni and Prof. Tomas Olsson about the evolving science connecting infections, immunity and multiple sclerosis.
Together, they explore:
- Molecular mimicry and how EBV proteins may trigger autoimmune responses
- Whether EBV contributes to chronic CNS inflammation and disease progression
- Emerging therapeutic approaches including antivirals, CAR-T cells, and vaccines
This conversation examines one of the most important scientific questions in MS research and the therapeutic possibilities that may emerge from it.
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment